Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 14.

Kahn, René S; Winter van Rossum, Inge; Leucht, Stefan; et al; Berger, Gregor; OPTiMiSE study group (2018). Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study. The Lancet Psychiatry, 5(10):797-807.

Re, Silvano; Dogan, Asli Aybike; Ben-Shachar, Dorit; Berger, Gregor; Werling, Anna Maria; Walitza, Susanne; Grünblatt, Edna (2018). Improved Generation of Induced Pluripotent Stem Cells From Hair Derived Keratinocytes - A Tool to Study Neurodevelopmental Disorders as ADHD. Frontiers in Cellular Neuroscience, 12:321.

Nelson, B; Amminger, G P; Yuen, H P; Markulev, C; Lavoie, S; Schäfer, M R; Hartmann, J A; Mossaheb, N; Schlögelhofer, M; Smesny, S; Hickie, I B; Berger, Gregor; Chen, E Y H; de Haan, L; Nieman, D H; Nordentoft, M; Riecher-Rössler, A; Verma, S; Thompson, A; Yung, A R; McGorry, P D (2018). NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders-medium-term follow-up and clinical course. npj Schizophrenia, 4:11.

Kaiser, Stefan; Berger, Gregor; Conus, Philippe; Kawohl, Wolfram; Müller, Thomas J; Schimmelmann, Benno G; Traber, Rafael; Trächsel, Nathalie; Vauth, Roland; Seifritz, Erich (2018). Die SGPP-Behandlungsempfehlungen zur Schizophrenie. Swiss Medical Forum, 18(25):532-539.

Polari, Andrea; Lavoie, Suzie; Yuen, Hok-Pan; Amminger, Paul; Berger, Gregor; Chen, Eric; deHaan, Lieuwe; Hartmann, Jessica; Markulev, Connie; Melville, Fritha; Nieman, Dorien; Nordentoft, Merete; Riecher-Rössler, Anita; Smesny, Stefan; Stratford, John; Verma, Swapna; Yung, Alison; McGorry, Patrick; Nelson, Barnaby (2018). Clinical trajectories in the ultra-high risk for psychosis population. Schizophrenia Research, 197:550-556.

Berger, Gregor. Bioactive Lipids in Early Psychosis. 2018, University of Zurich, Faculty of Medicine.

Re, Silvano; Werling, Anna; Berger, Gregor; Walitza, Susanne; Grünblatt, Edna (2017). Modelling attention-deficit hyperactivity disorder: From hair follicles to neurons using induced pluripotent stem cells. Leading Opinions. Neurologie & Psychiatrie, 17(5):31-33.

Berger, Gregor (2016). Comments on Bozzatello et al. Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data. J. Clin. Med. 2016, 5, 67. Journal of clinical medicine, 5(8):E69.

Walitza, Susanne; Berger, Gregor (2016). (Neue) Medikamente bei ADHS. Kinderärzte Schweiz, 2016(1):22-23.

Franscini, Maurizia; Berger, Gregor (2016). Schizophrene Störungen bei Kindern und Jugendlichen: Früherkennung verbessert die Prognose. Zürich, PRIME PUBLIC MEDIA AG: medizinonline.ch Fachportal für Ärzte.

Berger, Gregor; Franscini, Maurizia (2016). Verändertes Erleben, Stimmen hören. In: Albermann, Kurt. Wenn Kinder aus der Reihe tanzen. Psychische Entwicklungsstörungen von Kindern und Jugendlichen erkennen und behandeln. Zürich: Beobachter-Edition Ringier Axel Springer Schweiz AG, 289-309.

Schlögelhofer, Monika; Amminger, G Paul; Schaefer, Miriam R; Fusar-Poli, Paolo; Smesny, Stefan; McGorry, Pat; Berger, Gregor; Mossaheb, Nilufar (2014). Polyunsaturated fatty acids in emerging psychosis: a safer alternative? Early intervention in psychiatry, 8(3):199-208.

Berger, Gregor (2014). Chancen und Risiken. Fritz + Fränzi, (1):56-66.

Franscini, Maurizia; Berger, Gregor (2014). Psychosen – früh erkennen und Hilfe suchen. Fritz + Fränzi, (6):62-67.

This list was generated on Sun Apr 21 04:18:43 2019 CEST.